The many causes of quality of life deficits in cancer patients

International Journal of Pharmaceutical Medicine

Volumn 14, Issue 2, 2000, Pages 70-73

  Khayat, David ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cancer; Chemotherapy; Hormonal therapy; Long term survivors; Quality of life

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; DOXORUBICIN; TRASTUZUMAB;

ALOPECIA; BONE MARROW SUPPRESSION; CACHEXIA; CANCER PATIENT; CANCER THERAPY; CARDIOTOXICITY; CONFERENCE PAPER; DEPRESSION; FATIGUE; HUMAN; LUNG TOXICITY; MUCOSA INFLAMMATION; NAUSEA; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; VOMITING;

EID: 0034076783     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124363-200004000-00005     Document Type: Conference Paper

References (11)

1. 1. Black RJ, Bray F, Ferlay J, Parkin DM. Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990 [published erratum appears in Eur J Cancer 1997;33(14):2440]. Eur J Cancer 1997;33:1075-107.
2. 2. Lindley C, Vasa S, Sawyer WT, Winer EP. Quality of life and preferences for treatment following systemic adjuvant therapy for early-stage breast cancer. J Clin Oncol 1998; 16:1380-87.
3. 3. Ries LAG, Kosary CL, Hankey BF, Miller BA, Clegg L, Edwards BK. SEER Cancer Statistics Review, 1973-1996. Bethesda, MD: National Cancer Institute; 1999.
4. 4. Chang C, Bresnahan B, Gagnon D, Lent L, Zagari M, McNulty P, et al. Cross-language validation of the Functional Assessment of Cancer Therapy -Anaemia (FACT-An) questionnaire. Eur J Cancer 1999; 35 (Suppl 4):S359.
5. 5. Grossman SA, Scheidler VR. Pain. In: Clinical Oncology. Abeloff MD, Armitage JO, Lichter AS, Niederhuber JE (eds). New York: Churchill Livingstone; 1995, pp. 357-71.
6. 6. Souba WW. Nutritional Support. In: Principles and Practice of Oncology. De Vita VT, Hellman S, Rosenberg SA (eds), 5th edition. Philadelphia: Lippincott-Raven; 1997, pp. 2841-57
7. 7. Hancock SL, Donaldson SS, Hoppe RT. Cardiac disease following treatment of Hodgkin's disease in children and adolescents [see comments]. J Clin Oncol 1993; 11:1208-15.
8. 8. Meistrich ML, Vassilopoulou-Sellin R, Lipschultz LI. Gonadal dysfunction. In: Principles of Oncology. DeVita VTH, Rosenberg SA (eds), 5th edition. Philadelphia: Lippincott-Raven Publishers; 1997, pp. 2758-73.
9. 9. Curt GA, Breitbart W, Cella DF, Groopman JE, Horning SJ, Itri L, er al. Impact of cancer-related fatigue on the lives of patients. J Clin Oncol 1999; 18:573a.
10. 10. Derogatis LR, Morrow GR, Fetting J, Penman D, Piasetsky S, Schmale AM, et al. The prevalence of psychiatric disorders among cancer patients. JAMA 1983; 249:751-7.
11. 11. Nolvadex (tamoxifen citrate) [Package insert]. In: Rev V 02/99. Wilmington DE USA: Zeneca Pharmaceuticals; 1999.